Lu L - Search Results

1

A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.

Zhu J, Liu W, Zhang M, Lu L, Pan H, He X, Wang N, Yang M, Yi H, Tang S. Zhu J, et al. Among authors: lu l. J Clin Pharm Ther. 2021 Oct;46(5):1288-1294. doi: 10.1111/jcpt.13452. Epub 2021 May 27. J Clin Pharm Ther. 2021. PMID: 34046917

2

Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.

Pan H, Yang M, Lu L, Tao B, He X, Chen H, Yi H, Tang S. Pan H, et al. Among authors: lu l. Pharmacogenet Genomics. 2019 Jun;29(4):84-90. doi: 10.1097/FPC.0000000000000370. Pharmacogenet Genomics. 2019. PMID: 30720667

3

Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.

Yang M, Zhang H, Tao B, Pan H, Lu L, Yi H, Tang S. Yang M, et al. Among authors: lu l. J Clin Pharm Ther. 2019 Aug;44(4):534-542. doi: 10.1111/jcpt.12818. Epub 2019 Feb 18. J Clin Pharm Ther. 2019. PMID: 30776144

4

The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients.

He X, Zhang H, Tao B, Yang M, Chen H, Lu L, Yi H, Pan H, Tang S. He X, et al. Among authors: lu l. J Clin Pharmacol. 2019 Jul;59(7):1014-1021. doi: 10.1002/jcph.1398. Epub 2019 Feb 28. J Clin Pharmacol. 2019. PMID: 30817003

5

Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.

Yang M, Pan H, Lu L, He X, Chen H, Tao B, Liu W, Yi H, Tang S. Yang M, et al. Among authors: lu l. BMJ Open. 2019 Mar 30;9(3):e027321. doi: 10.1136/bmjopen-2018-027321. BMJ Open. 2019. PMID: 30928962 Free PMC article.

6

Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.

Lu L, Tao B, Wei H, Chen H, He X, Pan H, Yang M, Yi H, Tang S. Lu L, et al. J Gene Med. 2019 Jun;21(6):e3096. doi: 10.1002/jgm.3096. Epub 2019 Jun 3. J Gene Med. 2019. PMID: 31066138

7

Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.

Chen S, Pan H, Chen Y, Lu L, He X, Chen H, Chen R, Zhan S, Tang S. Chen S, et al. Among authors: lu l. Sci Rep. 2019 Oct 4;9(1):14311. doi: 10.1038/s41598-019-50706-y. Sci Rep. 2019. PMID: 31586142 Free PMC article.

8

Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.

Yang M, Pan H, Chen H, Liu W, Lu L, He X, Yi H, Tang S. Yang M, et al. Among authors: lu l. Infect Genet Evol. 2020 Sep;83:104349. doi: 10.1016/j.meegid.2020.104349. Epub 2020 May 7. Infect Genet Evol. 2020. PMID: 32387752

9

The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.

Zhang M, Zhu J, Wang N, Liu W, Lu L, Pan H, He X, Yi H, Tang S. Zhang M, et al. Among authors: lu l. J Clin Pharm Ther. 2022 Aug;47(8):1276-1283. doi: 10.1111/jcpt.13672. Epub 2022 Apr 25. J Clin Pharm Ther. 2022. PMID: 35470464

10

Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.

Liu W, Lu L, Pan H, He X, Zhang M, Wang N, Zhu J, Yi H, Tang S. Liu W, et al. Among authors: lu l. Pharmacogenomics. 2022 May;23(7):431-441. doi: 10.2217/pgs-2022-0015. Epub 2022 Apr 26. Pharmacogenomics. 2022. PMID: 35470713 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,030 results

Search Page

Filters